# Kwok‐Kin Wong

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kwok-kin-wong/

## Facts

| Field | Value |
| --- | --- |
| Citations | 74,517 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 143 |
| i10-index | 362 |
| Last Known Institution | Breast Cancer Research Foundation |
| OpenAlex ID | https://openalex.org/A5019034689 |
| ORCID iD | https://orcid.org/0000-0001-6323-235X |
| Works | 1,689 |

## Researcher papers

Showing 12 of 20.

- [<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma](https://scholariq.org/papers/i-stk11-lkb1-i-mutations-and-pd-1-inhibitor-resistance-in-i-kras-i-mutant-lung/)
- [Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints](https://scholariq.org/papers/adaptive-resistance-to-therapeutic-pd-1-blockade-is-associated-with-upregulation/)
- [Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors](https://scholariq.org/papers/activation-of-the-pd-1-pathway-contributes-to-immune-escape-in-egfr-driven-lung/)
- [SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas](https://scholariq.org/papers/sox2-is-an-amplified-lineage-survival-oncogene-in-lung-and-esophageal-squamous/)
- [Co-occurring Genomic Alterations Define Major Subsets of <i>KRAS</i> -Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities](https://scholariq.org/papers/co-occurring-genomic-alterations-define-major-subsets-of-i-kras-i-mutant-lung/)
- [CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation](https://scholariq.org/papers/cdk4-6-inhibition-augments-antitumor-immunity-by-enhancing-t-cell-activation/)
- [Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors](https://scholariq.org/papers/genomic-correlates-of-response-to-immune-checkpoint-blockade-in-microsatellite/)
- [STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment](https://scholariq.org/papers/stk11-lkb1-deficiency-promotes-neutrophil-recruitment-and-proinflammatory/)
- [<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids](https://scholariq.org/papers/i-ex-vivo-i-profiling-of-pd-1-blockade-using-organotypic-tumor-spheroids/)
- [Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway](https://scholariq.org/papers/treatment-induced-tumor-dormancy-through-yap-mediated-transcriptional/)
- [Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer](https://scholariq.org/papers/mutations-in-the-i-ddr2-i-kinase-gene-identify-a-novel-therapeutic-target-in/)
- [A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response](https://scholariq.org/papers/a-murine-lung-cancer-co-clinical-trial-identifies-genetic-modifiers-of/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)

## Researcher university

- [Breast Cancer Research Foundation](https://scholariq.org/institutions/breast-cancer-research-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.